Navigation Links
Tulane receives $15 million NIH contract to develop vaccine and treatment for deadly fever
Date:2/9/2010

The National Institute of Allergies and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has awarded a five-year contract totaling $15,254,919 to Tulane University for its ongoing efforts to treat and prevent Lassa fever, an often deadly viral disease that threatens hundreds of thousands of people annually in West Africa and is classified as a potential bioterrorism threat.

The contract will include collaboration between Tulane; Scripps Research Institute; The Broad Institute; Harvard University; the University of California at San Diego; Boston University; Autoimmune Technologies, LLC; Corgenix Medical Corporation and various partners in West Africa.

Dr. James Robinson, professor of pediatrics at Tulane University School of Medicine and principal investigator of the program, said researchers plan to evaluate antibodies from patients who were infected by the Lassa virus and recovered, to see if those antibodies might play a role in the development of a vaccine or treatment for the illness.

"This study will result in a fundamental understanding of the mechanisms of antibody responses and how they neutralize the Lassa virus," Robinson said. "We have assembled a very strong and diverse group of institutions to collaborate on this project."

In some areas of Sierra Leone, up to 16 percent of people admitted to hospitals have Lassa fever. Lassa fever is also associated with occasional epidemics, during which the fatality rate can reach 50 percent.

But Dr. Robert Garry, professor of microbiology and immunology at Tulane, who serves as program manager of the contract, sees hope.

"We have been very pleased with the results of our research efforts over the past five years," he said. "The diagnostic products we have developed have been shown to be remarkably effective in clinical settings in Africa, and will not only have a meaningful impact on health care in that part of the world, but will also fill a critical gap in bioterrorism defense. Now under the new NIH award, we will move to the next level allowing us to better treat the disease, or ultimately prevent it altogether."

Another team member, Dr. Daniel Bausch, associate professor of tropical medicine at Tulane University School of Public Health and Tropical Medicine, says that the group intends to expand this program to address other important infectious agents such as Ebola, Marburg and other hemorrhagic fever viruses that are of concern to the public health and bioterrorism preparedness communities.


'/>"/>

Contact: Arthur Nead
anead@tulane.edu
Tulane University
Source:Eurekalert

Related biology news :

1. Tulane receives grant to study limb regeneration
2. Carnegie Mellons John Kitchin receives early career award
3. Jedi Mind Receives Vast Media Coverage at CES in Las Vegas
4. University of Maryland School of Medicine receives $30 million to coordinate stem cell consortium
5. GenWay Clinical Laboratory receives accreditation from College of American Pathologists
6. Editor of Springer classic human genetics reference receives prize
7. Lehigh University professor receives Astellas Award for arsenic groundwater remediation efforts
8. University of California, San Francisco, researcher receives ASBMB-Merck Award
9. IGC scientist receives prestigious EMBO installation grant
10. UT Southwestern receives $700,000 from HHMI to promote medical education of Ph.D. students
11. Einstein receives high-risk/high-reward cancer research funding
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/11/2017)... April 11, 2017 NXT-ID, Inc. (NASDAQ: ... company, announces the appointment of independent Directors Mr. Robin ... its Board of Directors, furthering the company,s corporate governance and ... Gino Pereira ... look forward to their guidance and benefiting from their considerable ...
(Date:4/5/2017)... LONDON , April 4, 2017 KEY ... is anticipated to expand at a CAGR of 25.76% ... neurodegenerative diseases is the primary factor for the growth ... full report: https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The ... of product, technology, application, and geography. The stem cell ...
(Date:3/30/2017)... , March 30, 2017 The research team ... for three-dimensional (3D) fingerprint identification by adopting ground breaking 3D fingerprint ... new realm of speed and accuracy for use in identification, crime ... affordable cost. ... A ...
Breaking Biology News(10 mins):
(Date:4/20/2017)... /PRNewswire/ - Prometic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) ("Prometic" ... Liver Congress ("ILC") 2017 of the European Association for the ... on the positive effects of PBI-4050 on reduction of ... metabolic syndrome. ... Dr. Lyne Gagnon, Vice-President of R&D Pre-clinical of Prometic "This ...
(Date:4/20/2017)... , April 20, 2017 Dutch philosopher Koert van ... ,Next Nature, at the University of Technology in Eindhoven - has written ... this letter, he calls on humanity to avoid becoming a slave and victim ... ... Dutch philosopher Koert van Mensvoort – founder of the ...
(Date:4/19/2017)... ... April 18, 2017 , ... A number of new instruments ... which is part of the Protein and Cell Analysis Education Webinar Series , ... this technology fits in current and future applications. , Many flow cytometers have ...
(Date:4/19/2017)... ... April 19, 2017 , ... ThermaGenix, the PCR Improvement Company, ... to several other early achievements at ThermaGenix, including the business formation and licensing ... ThermaGenix will use proceeds from the Series A-1 round to:, ...
Breaking Biology Technology: